MIGRAINE AS A NEUROINFLAMMATORY DISEASE: PATHOPHYSIOLOGY, TREATMENT, AND IMPACT OF PHYSICAL EXERCISE
Abstract
Migraine is a common and disabling neurological disorder now recognized as a neuroinflammatory condition. Its pathophysiology involves interactions between neurons, glial cells, vascular structures, and immune pathways, with critical roles played by pro-inflammatory cytokines, CGRP signaling, microglial activation, and mitochondrial dysfunction. These factors contribute to pain sensitization and chronic inflammation in the brain. This review summarizes current understanding of migraine as a neuroinflammatory disease, examining both pharmacological and non-pharmacological treatment strategies. Acute therapies include NSAIDs, triptans, and CGRP antagonists, while preventive options involve antiepileptics, beta-blockers, and monoclonal antibodies targeting CGRP. Beyond medications, lifestyle factors such as stress, sleep disorders, poor diet, and gut dysbiosis are shown to exacerbate migraine through inflammatory pathways. Special emphasis is placed on the role of physical exercise, which has demonstrated anti-inflammatory and neuromodulatory effects. Regular aerobic activity can reduce migraine frequency, duration, and intensity by lowering inflammatory markers and improving vascular and hormonal balance. Other supportive strategies include dietary modifications, probiotic supplementation, and patient education within a biopsychosocial framework. A multidisciplinary and personalized approach, combining medication, exercise, nutrition, and education, offers the most promise for long-term migraine management and improved quality of life.
References
Aguilar-Shea, A. L., Membrilla Md, J. A., & Diaz-de-Teran, J. (2022). Migraine review for general practice. Atención Primaria, 54(2), 102208. https://doi.org/10.1016/j.aprim.2021.102208
Amani, H., Soltani Khaboushan, A., Terwindt, G. M., & Tafakhori, A. (2023). Glia Signaling and Brain Microenvironment in Migraine. Molecular Neurobiology, 60(7), 3911–3934. https://doi.org/10.1007/s12035-023-03300-3
Barber, M., & Pace, A. (2020). Exercise and Migraine Prevention: A Review of the Literature. Current Pain and Headache Reports, 24(8), 39. https://doi.org/10.1007/s11916-020-00868-6
Cavestro, C. (2025). Metabolic Dysfunction and Dietary Interventions in Migraine Management: The Role of Insulin Resistance and Neuroinflammation—A Narrative and Scoping Review. Brain Sciences, 15(5), 474. https://doi.org/10.3390/brainsci15050474
Cerqueira, É., Marinho, D. A., Neiva, H. P., & Lourenço, O. (2020). Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review. Frontiers in Physiology, 10. https://doi.org/10.3389/fphys.2019.01550
Cohen, F., Yuan, H., DePoy, E. M. G., & Silberstein, S. D. (2022). The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine. Neurotherapeutics, 19(3), 922–930. https://doi.org/10.1007/s13311-022-01230-x
Edvinsson, L., Haanes, K. A., & Warfvinge, K. (2019). Does inflammation have a role in migraine? Nature Reviews Neurology, 15(8), 483–490. https://doi.org/10.1038/s41582-019-0216-y
Ferini-Strambi, L., Galbiati, A., & Combi, R. (2019). Sleep disorder-related headaches. Neurological Sciences, 40(S1), 107–113. https://doi.org/10.1007/s10072-019-03837-z
Flynn, M. G., McFarlin, B. K., & Markofski, M. M. (2007). State of the Art Reviews: The Anti-Inflammatory Actions of Exercise Training. American Journal of Lifestyle Medicine, 1(3), 220–235. https://doi.org/10.1177/1559827607300283
Gazerani, P. (2020). Migraine and Diet. Nutrients, 12(6), 1658. https://doi.org/10.3390/nu12061658
Ghavami, A., Khorvash, F., Heidari, Z., Khalesi, S., & Askari, G. (2021). Effect of synbiotic supplementation on migraine characteristics and inflammatory biomarkers in women with migraine: Results of a randomized controlled trial. Pharmacological Research, 169, 105668. https://doi.org/10.1016/j.phrs.2021.105668
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017). Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiological Reviews, 97(2), 553–622. https://doi.org/10.1152/physrev.00034.2015
Haghdoost, F., & Togha, M. (2022). Migraine management: Non-pharmacological points for patients and health care professionals. Open Medicine, 17(1), 1869–1882. https://doi.org/10.1515/med-2022-0598
Inan, L. E. (2024). A path to better quality of life in migraine: The biopsychosocial approach. Dusunen Adam: Journal of Psychiatry and Neurological Sciences, 119–121. https://doi.org/10.14744/dajpns.2024.00249
Irby, M. B., Bond, D. S., Lipton, R. B., Nicklas, B., Houle, T. T., & Penzien, D. B. (2016). Aerobic Exercise for Reducing Migraine Burden: Mechanisms, Markers, and Models of Change Processes. Headache: The Journal of Head and Face Pain, 56(2), 357–369. https://doi.org/10.1111/head.12738
Kursun, O., Yemisci, M., Van Den Maagdenberg, A. M. J. M., & Karatas, H. (2021). Migraine and neuroinflammation: The inflammasome perspective. The Journal of Headache and Pain, 22(1), 55. https://doi.org/10.1186/s10194-021-01271-1
La Touche, R., Fierro-Marrero, J., Sánchez-Ruíz, I., Rodríguez De Rivera-Romero, B., Cabrera-López, C. D., Lerma-Lara, S., Requejo-Salinas, N., De Asís-Fernández, F., Elizagaray-García, I., Fernández-Carnero, J., Matesanz-García, L., Pardo-Montero, J., Paris-Alemany, A., & Reina-Varona, Á. (2023). Prescription of therapeutic exercise in migraine, an evidence-based clinical practice guideline. The Journal of Headache and Pain, 24(1), 68. https://doi.org/10.1186/s10194-023-01571-8
Levis, A. A., Caverni, C. N., Wille, J., & Santos, P. S. F. (2024). The relationship between the gut-brain axis and migraine. Headache Medicine, 15(3), 119–122. https://doi.org/10.48208/headachemed.2024.26
Mykland, M. S., Uglem, M., Neverdahl, J. P., Øie, L. R., Meisingset, T. W., Dodick, D. W., Tronvik, E., Engstrøm, M., Sand, T., & Omland, P. M. (2022). Sleep restriction alters cortical inhibition in migraine: A transcranial magnetic stimulation study. Clinical Neurophysiology, 139, 28–42. https://doi.org/10.1016/j.clinph.2022.04.004
Nguyen, K. V., & Schytz, H. W. (2024). The Evidence for Diet as a Treatment in Migraine—A Review. Nutrients, 16(19), 3415. https://doi.org/10.3390/nu16193415
On behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS), Arzani, M., Jahromi, S. R., Ghorbani, Z., Vahabizad, F., Martelletti, P., Ghaemi, A., Sacco, S., & Togha, M. (2020). Gut-brain Axis and migraine headache: A comprehensive review. The Journal of Headache and Pain, 21(1). https://doi.org/10.1186/s10194-020-1078-9
Pavlovic, J. M., Buse, D. C., Sollars, C. M., Haut, S., & Lipton, R. B. (2014). Trigger Factors and Premonitory Features of Migraine Attacks: Summary of Studies. Headache: The Journal of Head and Face Pain, 54(10), 1670–1679. https://doi.org/10.1111/head.12468
Peng, K.-P., & May, A. (2020). Redefining migraine phases – a suggestion based on clinical, physiological, and functional imaging evidence. Cephalalgia, 40(8), 866–870. https://doi.org/10.1177/0333102419898868
Peroutka, S. J. (2014). What Turns on a Migraine? A Systematic Review of Migraine Precipitating Factors. Current Pain and Headache Reports, 18(10). https://doi.org/10.1007/s11916-014-0454-z
Persson, M., Rembeck, G., & Weineland, S. (2023). Conceptualising migraine attacks from a biopsychosocial model using qualitative and functional behavioural analysis. Scandinavian Journal of Primary Health Care, 41(3), 257–266. https://doi.org/10.1080/02813432.2023.2231034
Petersen, A. M. W., & Pedersen, B. K. (2005). The anti-inflammatory effect of exercise. Journal of Applied Physiology, 98(4), 1154–1162. https://doi.org/10.1152/japplphysiol.00164.2004
Qubty, W., & Patniyot, I. (2020). Migraine Pathophysiology. Pediatric Neurology, 107, 1–6. https://doi.org/10.1016/j.pediatrneurol.2019.12.014
Ramachandran, R. (2018). Neurogenic inflammation and its role in migraine. Seminars in Immunopathology, 40(3), 301–314. https://doi.org/10.1007/s00281-018-0676-y
Rosignoli, C., Ornello, R., Onofri, A., Caponnetto, V., Grazzi, L., Raggi, A., Leonardi, M., & Sacco, S. (2022). Applying a biopsychosocial model to migraine: Rationale and clinical implications. The Journal of Headache and Pain, 23(1). https://doi.org/10.1186/s10194-022-01471-3
Sevivas, H., & Fresco, P. (2022). Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: A systematic review. European Journal of Medical Research, 27(1). https://doi.org/10.1186/s40001-022-00716-w
Smith, T. R., Nicholson, R. A., & Banks, J. W. (2010). Migraine Education Improves Quality of Life in a Primary Care Setting. Headache: The Journal of Head and Face Pain, 50(4), 600–612. https://doi.org/10.1111/j.1526-4610.2010.01618.x
Song, Y., Zhao, S., Peng, P., Zhang, C., Liu, Y., Chen, Y., Luo, Y., Li, B., & Liu, L. (2024). Neuron-glia crosstalk and inflammatory mediators in migraine pathophysiology. Neuroscience, 560, 381–396. https://doi.org/10.1016/j.neuroscience.2024.10.006
Tanaka, M., Tuka, B., & Vécsei, L. (2024). Navigating the Neurobiology of Migraine: From Pathways to Potential Therapies. Cells, 13(13), 1098. https://doi.org/10.3390/cells13131098
Therapeutic role of melatonin in migraine prophylaxis: Is there a link between sleep and migraine? (2020). In T.-J. Song, B.-S. Kim, & M. K. Chu, Progress in Brain Research (pp. 343–369). Elsevier. https://doi.org/10.1016/bs.pbr.2020.05.014
Viganò, A., Toscano, M., Puledda, F., & Di Piero, V. (2019). Treating Chronic Migraine With Neuromodulation: The Role of Neurophysiological Abnormalities and Maladaptive Plasticity. Frontiers in Pharmacology, 10, 32. https://doi.org/10.3389/fphar.2019.00032
Zobdeh, F., Ben Kraiem, A., Attwood, M. M., Chubarev, V. N., Tarasov, V. V., Schiöth, H. B., & Mwinyi, J. (2021). Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments. British Journal of Pharmacology, 178(23), 4588–4607. https://doi.org/10.1111/bph.15657
Views:
30
Downloads:
16
Copyright (c) 2025 Agnieszka Ozdarska, Agnieszka Floriańczyk, Ewa Romanowicz, Aleksandra Kołdyj, Adrian Krzysztof Biernat, Marcin Lampart, Anna Rupińska, Kamila Krzewska, Hanna Skarakhodava
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
